Charles Schwab’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $836K | Buy |
224,220
+17,770
| +9% | +$66.3K | ﹤0.01% | 2955 |
|
|
2025
Q1 | $570K | Hold |
206,450
| – | – | ﹤0.01% | 3037 |
|
|
2024
Q4 | $1.14M | Buy |
206,450
+51,736
| +33% | +$287K | ﹤0.01% | 2867 |
|
|
2024
Q3 | $1.29M | Buy |
154,714
+1,994
| +1% | +$16.6K | ﹤0.01% | 2839 |
|
|
2024
Q2 | $1.04M | Buy |
152,720
+38,111
| +33% | +$260K | ﹤0.01% | 2919 |
|
|
2024
Q1 | $752K | Hold |
114,609
| – | – | ﹤0.01% | 2881 |
|
|
2023
Q4 | $744K | Hold |
114,609
| – | – | ﹤0.01% | 2928 |
|
|
2023
Q3 | $576K | Hold |
114,609
| – | – | ﹤0.01% | 2992 |
|
|
2023
Q2 | $1M | Buy |
114,609
+100,898
| +736% | +$883K | ﹤0.01% | 2763 |
|
|
2023
Q1 | $162K | Buy |
+13,711
| New | +$162K | ﹤0.01% | 3190 |
|
|
2022
Q4 | – | Sell |
-12,408
| Closed | -$74K | – | 3563 |
|
|
2022
Q3 | $74K | Buy |
+12,408
| New | +$74K | ﹤0.01% | 3249 |
|
|
2022
Q2 | – | Sell |
-28,746
| Closed | -$86K | – | 3638 |
|
|
2022
Q1 | $86K | Hold |
28,746
| – | – | ﹤0.01% | 3439 |
|
|
2021
Q4 | $204K | Sell |
28,746
-2,797
| -9% | -$19.8K | ﹤0.01% | 3356 |
|
|
2021
Q3 | $329K | Buy |
31,543
+10,184
| +48% | +$106K | ﹤0.01% | 3244 |
|
|
2021
Q2 | $262K | Hold |
21,359
| – | – | ﹤0.01% | 3253 |
|
|
2021
Q1 | $470K | Buy |
+21,359
| New | +$470K | ﹤0.01% | 3101 |
|